Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 296 results for "Pradaxa Lawsuits"

Correction of Press Release Dated May 11, 2015, Regarding the ...

press release from Gudeman Group erroneously stated that the Onder Law Firm is currently investigating claims for possible inclusion in future Pradaxa lawsuits, and misquoted Attorney Jim Onder stating the same. In fact, the Onder Law Firm is ... PRWeb, 1 week ago

Pradaxa Lawsuit News: Settlements Disbursed, New Cases Filed

More than 3,000 claimants have already received settlement payments for Pradaxa lawsuits according to attorneys handling national Pradaxa claims alleging severe internal bleeding for the Onder Law Firm. Attorneys handling national Pradaxa lawsuits ...
 PRWeb2 weeks ago Possible Lawsuit: Bleeding Deaths Associated with Pradaxa  Lawyers & Settlements3 weeks ago

Boehringer Ingelheim seeks FDA approval for Pradaxa to treat DVT and PE

Legal-Bay LLC, The Lawsuit Settlement Funding Company, announced today that Pradaxa's maker, Boehringer Ingelheim Pharmaceuticals, is seeking FDA approval for its blood thinner to treat DVT and PE. According to PBR, Boehringer submitted a ...
 News-Medical.Net1 month ago Legal-Bay Lawsuit Settlement Funding Announces Readiness to Fund Cases in Memorial Day Rush within 24 Hours  International Business Times5 days ago Pradaxa Maker Boehringer Ingelheim Pharmaceuticals Pursues Pradaxa FDA Approval to treat DVT and PE  Industrial Info Financials1 month ago Xarelto Litigation Update: Legal-Bay Lawsuit Settlement Funding Reports Issuance of New Court Documents  Ulitzer1 month ago

Xarelto News Update: New Court Documents Issued in Two Courts, Says

/PRNewswire/ --MT Services LLC, a Lawsuit Settlement News Reporting Company which operates, announced today that two new court documents have been issued in consolidated litigations over Xarelto in Louisiana and ...
 Wall Street Business Network1 month ago GranuFlo and NaturaLyte Bellwether Trials to Start in January of 2016, Says  Sys-Con Media2 months ago

Law Firm Starts Two Suits for Deaths of Users of Xarelto

/PRNewswire/ -- The New York City law firm of this week commenced two wrongful death lawsuits, each involving the death of a user of the blood thinner Xarelto. In each case it is alleged that the drug is misleadingly marketed as a "one size fits ...
 Freshnews.com1 month ago

Lawyer Ellen Relkin Discusses Xarelto Bleeding, Wound Infections

Amid growing concerns about the link between the blood-thinner Xarelto (rivaroxaban) to dangerous bleeding risks, a new serious side effect of the drug is coming to the forefront: post-surgical infections that could send people back into the ...
 Drug Watch3 weeks ago

Xarelto Litigation Update Jacksonville Filing

Brenda S. Fulmer, a 21-year veteran of drug and medical device litigation and a partner with Searcy Denney, filed an indivdual lawsuit against the manufacturers of Xarelto in federal court in Jacksonvillle this week. The case is a wrongful death ...
 JD Supra1 month ago
Inside Counsel

Action is needed to confront spoliation creep

Inside counsel often feel like they have no choice but to pay the high premium of over preservation The first article in this series considered how the historic and universal principles of fair play that are the bedrock of the spoliation doctrine ...
 Inside Counsel1 month ago
Japan Times

Drugmaker Takeda may settle Actos suits for $2.2 billion

Takeda Pharmaceutical Co. has offered to pay more than $2.2 billion to resolve claims it hid cancer risks related to its Actos diabetes medicine in what would be one of the largest U.S. settlements of patient lawsuits targeting drugs or devices, ...
 Japan Times1 month ago

Breckenridge Pharmaceutical Updates on Paragraph IV ANDA Litigation with Boehringer Ingelheim for Its ANDA Dabigatran Etexilate Mesylate Capsules... [Manufacturing Close - Up]

Breckenridge Pharmaceutical Updates on Paragraph IV ANDA Litigation with Boehringer Ingelheim for Its ANDA Dabigatran Etexilate Mesylate Capsules (Pradaxa) Breckenridge Pharmaceutical reported that it has filed an ANDA with a Paragraph IV ...
 Pharmacy Choice2 months ago Breckenridge Pharmaceutical Reports on Paragraph IV ANDA Litigation with Boehringer Ingelheim for Its ANDA Dabigatran Etexilate Mesylate Capsules... [Health & Beauty Close - Up]  Pharmacy Choice2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less